Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 56Lung Neoplasms 29Triple Negative Breast Neoplasms 13Breast Neoplasms 13Ovarian Neoplasms 12Endometrial Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Small Cell Lung Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 11Neoplasms 10Fallopian Tube Neoplasms 10Neoplasm Metastasis 8Colorectal Neoplasms 5Adenocarcinoma of Lung 5Carcinoma 4Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Melanoma 3Lung Diseases 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thoracic Neoplasms 2Sarcoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Rectal Neoplasms 2Prostatic Neoplasms 2Pathologic Complete Response 2Non-squamous Non-small Cell Lung Cancer 2

Interventions

Magnetic Resonance Spectroscopy 9Specimen Handling 8Cisplatin 5Cetuximab 5Platinum 41,2-diaminocyclohexaneplatinum II citrate 4cemiplimab 3Radiotherapy 3Immunoglobulin G 3Disulfides 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3pembrolizumab 2Radiotherapy, Intensity-Modulated 2Radiation 2Nivolumab 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1temsirolimus 1niraparib 1ipatasertib 1durvalumab 1dostarlimab 1cabozantinib 1atezolizumab 1Valproic Acid 1Ultrasonography 1Transurethral Resection of Bladder 1Tramadol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mouth Neoplasms × Carboplatin × 30 days × Clear all
NCT05063552 2026-06-03

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
430 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07195734 2026-05-19

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Recruiting
180 enrolled
Head & Neck

Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡